UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041686
Receipt number R000047587
Scientific Title Survey research for patients with type 2 diabetes
Date of disclosure of the study information 2020/09/07
Last modified on 2020/09/07 20:27:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Survey research for patients with type 2 diabetes

Acronym

Survey research for patients with type 2 diabetes

Scientific Title

Survey research for patients with type 2 diabetes

Scientific Title:Acronym

Survey research for patients with type 2 diabetes

Region

Japan


Condition

Condition

Type 2 diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the relationship between consciousness and anxiety about treatment, motivation for treatment and patient background, and glycemic control in older adults with type 2 diabetes.

Basic objectives2

Others

Basic objectives -Others

Fact-finding survey

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1) Glycemic control (achieved / unachieved)
2) Awareness of diabetes treatment
3) Satisfaction with diabetes treatment
4) Compliance with drug treatment
5) Motivation for treatment
6) Anxiety about diabetes treatment
7) Flail
8) The potential of sarcopenia
9) Fall
10) Hypoglycemic symptoms
11) Cognitive function (memory, orientation), instrumental ADL and basic ADL

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Patients who are over 20 years old and have been diagnosed with type 2 diabetes
(2) Patients who are currently visiting the hospital and receiving drug treatment with diabetic drugs
(3) Patients whose HbA1c level was measured within 6 months before the start of the research
(4) Patients who have given their voluntary consent to participate in the research

Key exclusion criteria

(1) Patients who cannot confirm the use of diabetes medicine
(2) Patients whose HbA1c level cannot be confirmed within 6 months before the start of the research

Target sample size

400


Research contact person

Name of lead principal investigator

1st name Ryo
Middle name
Last name Suzuki

Organization

Tokyo Medical University

Division name

Department of Diabetes, Metabolism & Endocrinology

Zip code

160-0023

Address

6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo

TEL

03-3342-6111

Email

ryosuzuki-tky@umin.ac.jp


Public contact

Name of contact person

1st name Inquiry counter
Middle name
Last name Seikatu Kojo WEB

Organization

3H Clinical Trial Inc.

Division name

Inquiry counter of Seikatu Kojo WEB

Zip code

171-0022

Address

Ikebukuro YS Bldg.2F, 1-13-23 Minami-Ikebukuro, Toshima-ku, Tokyo

TEL

0120-963-787

Homepage URL


Email

info@c-trial.com


Sponsor or person

Institute

Tokyo Medical University

Institute

Department

Personal name



Funding Source

Organization

Sumitomo Dainippon Pharma Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Medical University Institutional Review Board

Address

6-7-1,Nishi-shinjuku,Shinjuku,Tokyo

Tel

03-3342-6111

Email

IRB@tokyo-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 09 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 03 Month 10 Day

Date of IRB

2020 Year 08 Month 05 Day

Anticipated trial start date

2020 Year 09 Month 07 Day

Last follow-up date

2021 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

We investigate the relationships between glycemic control and patient interest in diabetes management, motivation, anxiety for diabetes treatment, patient background in older adults with type 2 diabetes.


Management information

Registered date

2020 Year 09 Month 04 Day

Last modified on

2020 Year 09 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047587


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name